CS
LIMNW

Clear Street’s Liminatus Pharma Warrants LIMNW Stock Holding History

Clear Street’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4 Sell
100
-805,077
-100% -$51.5K ﹤0.01% 1096
2025
Q4 		$28.2K Sell
805,177
-200
-0% -$20 ﹤0.01% 686
2025
Q3 		$119K Sell
805,377
-100
-0% -$20 ﹤0.01% 389
2025
Q2 		$193K Buy
+805,477
New +$158K ﹤0.01% 217

Other funds holding LIMNW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street's LIMNW Position: Q1 2026 in Review

Clear Street reduced its Liminatus Pharma Warrants (LIMNW) stake by 100% in Q1 2026, selling an estimated $51.5K and leaving 100 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #1096.

Clear Street first reported a position in LIMNW in Q2 2025 and has held it in 4 quarters since. The position peaked at $193K in Q2 2025. 21 funds tracked by Wall St. Rank hold LIMNW as of Q1 2026.

  • Clear Street held 100 shares of Liminatus Pharma Warrants worth $4 as of Q1 2026.
  • Clear Street sold 805,077 Liminatus Pharma Warrants shares in Q1 2026, an estimated $51.5K.
  • Liminatus Pharma Warrants made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #1096 holding.
  • Clear Street first reported a position in Liminatus Pharma Warrants in Q2 2025 and has held it in 4 quarters since.
  • Clear Street's Liminatus Pharma Warrants position peaked at $193K in Q2 2025.
  • 21 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.